Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Damian, Doris
98  Ergebnisse:
Personensuche X
?
1

Outcomes of COVID-19 in people with multiple sclerosis trea..:

Jack, Dominic ; Damian, Doris ; Nolting, Axel.
Multiple Sclerosis and Related Disorders.  51 (2021)  - p. 102996 , 2021
Link: https://doi.org/10.1016/..
 
?
2

Subgroup analysis of clinical and MRI outcomes in participa..:

Cree, Bruce A.C. ; Bowen, James D. ; Hartung, Hans-Peter...
Multiple Sclerosis and Related Disorders.  49 (2021)  - p. 102695 , 2021
Link: https://doi.org/10.1016/..
 
?
3

Efficacy of cladribine tablets in high disease activity pat..:

Vermersch, Patrick ; Galazka, Andrew ; Dangond, Fernando...
Current Medical Research and Opinion.  37 (2021)  3 - p. 459-464 , 2021
Link: https://doi.org/10.1080/..
 
?
4

COVID-19 in patients with multiple sclerosis treated with c..:

Jack, Dominic ; Damian, Doris ; Nolting, Axel.
Multiple Sclerosis and Related Disorders.  51 (2021)  - p. 102929 , 2021
Link: https://doi.org/10.1016/..
 
?
5

Early MRI outcomes in participants with a first clinical de..:

Freedman, Mark S ; Coyle, Patricia K ; Comi, Giancarlo...
Multiple Sclerosis Journal - Experimental, Translational and Clinical.  7 (2021)  1 - p. 205521732199085 , 2021
Link: https://doi.org/10.1177/..
 
?
6

Updated Post-Approval Safety of Cladribine Tablets in the T..:

Giovannoni, Gavin ; Berger, Joseph ; Leist, Thomas...
Neurology.  96 (2021)  15_supplement - p. , 2021
Link: https://doi.org/10.1212/..
 
?
7

Étude CLARITY : résultats d'efficacité chez les patients ay..:

Vermersch, Patrick ; Rammohan, Kottil ; Damian, Doris...
Revue Neurologique.  176 (2020)  - p. S79 , 2020
Link: https://doi.org/10.1016/..
 
?
8

Updated Safety of Cladribine Tablets in the Treatment of Pa..:

Cook, Stuart ; Giovannoni, Gavin ; Leist, Thomas...
Multiple Sclerosis and Related Disorders.  37 (2020)  - p. 101599 , 2020
Link: https://doi.org/10.1016/..
 
?
9

Pregnancy Outcomes During the Clinical Development Program ..:

Giovannoni, Gavin ; Galazka, Andrew ; Schick, Regina...
Drug Safety.  43 (2020)  7 - p. 635-643 , 2020
Link: https://doi.org/10.1007/..
 
?
10

An analysis of the relationship between cladribine dose and..:

Cook, Stuart ; Giovannoni, Gavin ; Leist, Thomas...
Neurology.  94 (2020)  15_supplement - p. , 2020
Link: https://doi.org/10.1212/..
 
?
11

Updated safety of cladribine tablets in the treatment of pa..:

Cook, Stuart ; Giovannoni, Gavin ; Leist, Thomas...
Neurology.  94 (2020)  15_supplement - p. , 2020
Link: https://doi.org/10.1212/..
 
?
12

Updated safety analysis of cladribine tablets in the treatm..:

Cook, Stuart ; Giovannoni, Gavin ; Leist, Thomas...
Neurology.  92 (2019)  15_supplement - p. , 2019
Link: https://doi.org/10.1212/..
 
?
13

Cladribine tablets were associated with rapid onset of impr..:

Scarberry, Susan ; Damian, Doris ; Hyvert, Yann...
Neurology.  92 (2019)  15_supplement - p. , 2019
Link: https://doi.org/10.1212/..
 
?
14

Impact of Nonrandomized Dropout on Treatment Switching Adju..:

Gorrod, Helen Bell ; Latimer, Nicholas R. ; Damian, Doris...
Value in Health.  22 (2019)  7 - p. 772-776 , 2019
Link: https://doi.org/10.1016/..
 
?
15

The effect of cladribine tablets on delaying the time to co..:

Bowen, James ; Damian, Doris ; Hyvert, Yann...
Neurology.  92 (2019)  15_supplement - p. , 2019
Link: https://doi.org/10.1212/..
 
1-15